- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: tipranavir/ritonavir
Total 880 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedHIV InfectionsUnited States, Argentina, Brazil, France, Germany, Italy, Spain
-
Boehringer IngelheimCompleted
-
Germans Trias i Pujol HospitalFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...Completed
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedHIV InfectionsGermany, Italy, Spain
-
Boehringer IngelheimCompletedHIV InfectionsArgentina, Austria, Belgium, Brazil, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHIV InfectionsNetherlands, Germany, Canada, United States, France, United Kingdom, Switzerland, Denmark, Australia, Greece, Portugal, Belgium, Italy
-
Boehringer IngelheimCompleted
-
Yale UniversityBoehringer IngelheimCompletedHIV InfectionsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Johns Hopkins UniversityBoehringer IngelheimCompletedHIV InfectionsUnited States
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Germans Trias i Pujol HospitalFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...Completed
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Australia, Canada, Puerto Rico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedHIV InfectionsUnited States, Argentina, Brazil, Canada, Germany, Italy, Spain
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Puerto Rico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimApproved for marketingHIV InfectionsUnited States
-
Boehringer IngelheimTerminatedHIV InfectionsUnited States, Bahamas, Belgium, Canada, France, Germany, Greece, Italy, Portugal, Puerto Rico, Spain, Thailand
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimApproved for marketingHIV InfectionsBelgium, Brazil, Canada, Denmark, El Salvador, Greece, Italy, Portugal, Spain
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico, Netherlands, Portugal, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimWithdrawn
-
Boehringer IngelheimApproved for marketingHIV InfectionsUnited States, Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHIV InfectionsNetherlands, United States, Canada, Italy, Spain, Australia, Germany, France, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsUnited States, Puerto Rico, Thailand, Botswana, Argentina, Brazil, Tanzania, South Africa
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Completed
-
Karolinska InstitutetKarolinska University Hospital; PfizerRecruitingCOVID-19 | Post-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | POTS - Postural Orthostatic Tachycardia Syndrome | Postinfectious Inflammation | Postinfectious DisorderSweden
-
Drugs for Neglected DiseasesUniversity of Cape Town; Medecins Sans Frontieres, Netherlands; UBS Optimus Foundation and other collaboratorsCompletedAcquired Immunodeficiency Syndrome | TuberculosisSouth Africa